Evidence map›Paper›PMID 23856412›Full record

ReviewAdvanced drug delivery reviews2013

Peroxidase-mediated biodegradation of carbon nanotubes in vitro and in vivo.

Gregg P Kotchey, Yong Zhao, Valerian E Kagan, Alexander Star

Open access · greenAbstract readReview
In one paragraph

Review in Advanced drug delivery reviews, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
13.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 169 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. A New Look at the Effects of Engineered ZnO and TiONanomaterials (Basel, Switzerland) · 2022
    Review
  15. Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Gregg P KotcheyDepartment of Chemistry, University of Pittsburgh, Pittsburgh, PA, USA.
Yong Zhao
Valerian E Kagan
Alexander Star
University of Pittsburgh · US

Funding

Training and EducationU19AI068021 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI BAYIR, HÜLYA · 2005 to 2019
$44.4M
Lung Oxidative Stress/Inflammation By Carbon NanotubesR01OH008282 · OH · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KAGAN, VALERIAN E · 2005 to 2014
$2.8M
Investigations and Mitigation of Carbon Nanomaterial ToxicityR01ES019304 · NIEHS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI STAR, ALEXANDER · 2010 to 2014
$1.9M
NIAID NIH HHS U19 AI068021NIAID NIH HHS U19AI068021NIEHS NIH HHS R01 ES019304NIEHS NIH HHS R01ES019304NIOSH CDC HHS OH008282NIOSH CDC HHS R01 OH008282
6 · The paper itself

Abstract

As a result of their unique electronic, optical, and mechanical properties, carbon nanotubes (CNTs) have been implemented in therapeutic and imaging applications. In an idealized situation, CNTs would be disposed of after they transport their theranostic payloads. Biodegradation represents an attractive pathway for the elimination of CNT carriers post-delivery and may be integral in catalyzing the release of the cargo from the delivery vehicle. Accordingly, recent research efforts have focused on peroxidase-driven biodegradation of CNTs. In this review, we not only summarize recent efforts to biodegrade CNTs in the test tube, in vitro, and in vivo, but also attempt to explore the fundamental parameters underlying degradation. Encouraged by the in vivo results obtained to date, we envision a future, where carbon-based nano-containers, which are specifically designed to target organs/cells, deliver their cargo, and biodegrade via peroxidase-driven mechanism, will represent an attractive therapeutic delivery option in nanomedicine.

Indexed as

Drug Delivery SystemsAnimalsBrainDiagnostic ImagingHumansLungNanomedicineNanotubes, CarbonNeutrophilsOxidative StressPeroxidasesNanotubes, CarbonPeroxidasesBiodegradationCarbon nanotubesDrug deliveryGrapheneNanoparticlesPeroxidases

Identifiers

PMID23856412
PMCPMC3855904
OpenAlexW2147106450

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.